Clarithromycin 500mg tablets -Claranta

Claranta is a macrolide antibiotic. It acts by inhibiting microsomal protein synthesis by binding to the 50S subunit of the bacterial ribosome. Claranta is active against most gram-positive bacteria, Chlamydia, some gram-negative bacteria and Mycoplasmas. Claranta is a macrolide antibiotic whose spectrum of activity includes many gram-positive (Staphylococcus aureus, S. pneumoniae, and S. pyogenes) and gram-negative aerobic bacteria (Haemophilus influenzae, H. parainfluenzae, and Moraxella catarrhalis), many anaerobic bacteria, some mycobacteria, and some other organisms including Mycoplasma, Ureaplasma, Chlamydia, Toxoplasma, and Borrelia. Other aerobic bacteria that clarithromycin has activity against include C. pneumoniae and M. pneumoniae. Claranta has an in-vitro activity that is similar or greater than that of erythromycin against erythromycin-susceptible organisms. Claranta is usually bacteriostatic, but may be bactericidal depending on the organism and the drug concentration.